News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Strides Arcolab Limited, Pfizer Inc. (PFE) to Deal Post US FDA Nod on Oncology Unit



5/2/2011 7:22:30 AM

Money Control -- Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an exclusive interview with CNBC-TV18 shares that the company expects approvals on approximately USD 4-5 billon product filings with the US FDA over the next few weeks.

40 oncology drugs have been out licensed to Pfizer, and Kumar further confirms that the Pfizer partnership is the most impactful. He also says that this approval allows the company to operate in a niche space within US.


Read at Money Control
Read at Business Standard
Read at India Infoline
Read at Live Mint

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES